TCL Archive In Brief: NCI Funded To Dec. 15, No Senate Figure Yet; Speedup Urged On Interferon Manufacturing, Testing October 10, 1980
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents. March 31, 2000